Strategic partnerships Panalgo is actively expanding through strategic alliances, notably the 2026 Navidence partnership embedding validated patient definitions into the IHD platform, indicating a sales opportunity to collaborate with data vendors and phenotype definition providers to broaden data sources and workflow integration.

Cloud accessibility With IHD Cloud launches and AWS Marketplace availability (2024 2025), there is a clear path to upsell cloud-based deployments to enterprise customers seeking scalable, centralized real-world data analytics and faster time to insight.

Transparency and docs Recent enhancements adding automated documentation and transparency features position Panalgo to address regulatory and governance concerns, appealing to risk-averse healthcare organizations that require auditable analytics and traceability.

Real-world data focus The platform emphasizes real-world data and real-world evidence centralization, enabling conversations with health systems, payers, and life sciences firms about accelerating evidence generation and decision-making in clinical and commercial programs.

Scale and tech stack A modern, scalable tech stack including Kubernetes, Terraform, and security tools alongside Power BI integration suggests cross-sell opportunities to clients needing robust analytics, governance, and DevOps-friendly deployments at scale.